Sivik Global Healthcare
Sivik Global Healthcare reported 35 stocks worth $175M in its 13F filing for Q3 2026, filed Oct 13, 2026. Its largest holdings are XBI (16.2%), HUM (3.9%) and JNJ (3.6%). Compared with Q2 2026, the fund opened new positions in CNC, RVTY and BRKR, added to XBI, JNJ and ABBV, trimmed HUM, LLY and WAT and sold out of ISRG, AZN and BSX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  XBI Spdr Series Trust | $28.4M | 16.2% | 180K | +30K (+20%) | 8 of 8 | |
| 2 |  HUM Humana Inc | $6.8M | 3.9% | 18K | −2,300 (−12%) | 8 of 8 | |
| 3 |  JNJ Johnson & Johnson | $6.4M | 3.6% | 24K | +4,000 (+20%) | 4 of 8 | |
| 4 |  MRK Merck & Co Inc | $5.8M | 3.3% | 40K | No change | 4 of 8 | |
| 5 |  ABBV Abbvie Inc | $5.8M | 3.3% | 22K | +7,000 (+47%) | 6 of 8 | |
| 6 |  TMO Thermo Fisher Scientific Inc | $5.7M | 3.3% | 8,500 | +500 (+6%) | 5 of 8 | |
| 7 |  CAH Cardinal Health Inc | $5.6M | 3.2% | 25K | +1,000 (+4%) | 8 of 8 | |
| 8 |  MCK Mckesson Corp | $5.5M | 3.2% | 6,500 | +2,500 (+63%) | 8 of 8 | |
| 9 |  DHR Danaher Corp | $5.5M | 3.2% | 25K | +5,000 (+25%) | 8 of 8 | |
| 10 |  UNH Unitedhealth Group Inc | $5.5M | 3.1% | 15K | +5,000 (+50%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CALL- BSX 100 @ 75 EXP 04/17/2026 | $5K | 800 |
 ISRG Intuitive Surgical Inc | $4K | 9,000 |
 AZN Astrazeneca PLC Ord | $4K | 20K |
 BSX Boston Scientific Corp | $4K | 62K |
 THC Tenet Healthcare Corp | $4K | 20K |
🔒 Free account: see all 11.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Oct 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Sivik Global Healthcare 13F FAQ
What does Sivik Global Healthcare own?
Sivik Global Healthcare reported 35 stocks worth $175M in its 13F filing for Q3 2026, filed Oct 13, 2026. Its largest holdings are XBI (16.2%), HUM (3.9%) and JNJ (3.6%). The table above lists every position in the filing (the top 10 without an account).
What did Sivik Global Healthcare buy and sell in Q3 2026?
Compared with Q2 2026: 12 new positions, 14 added to, 5 trimmed and 11 sold out. New positions include CNC, RVTY and BRKR. It sold all of ISRG, AZN and BSX.
When will Sivik Global Healthcare file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Sivik Global Healthcare's portfolio worth?
The Q3 2026 filing reports $175M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.